International Targeted Oncology Drug Access Pathway国际特许肿瘤靶向与免疫联合治疗通道
国际特许肿瘤靶向与免疫联合治疗通道International Targeted Oncology Drug Access Pathway
A clinical navigation pathway providing early access to globally approved targeted drugs and immunotherapies before mainland registration, supported by multidisciplinary tumor profiling.一条临床导航路径。在大陆上市注册前，为患者提供获取全球已批准靶向药与免疫疗法的早鸟通道，并提供多学科肿瘤表型分析支持。
Delivering hospital交付医院
A tertiary oncology center providing liquid biopsies, precision chemotherapy, and fast-track access to globally approved targeted drugs under Lecheng policies.一家三级肿瘤专科中心，提供早期液态活检、精准化学疗法和快速获取全球已上市靶向药物的特许通道。
Regulatory basis监管依据
Lecheng International Special Drug Import Policy; clinical implementation monitored by provincial Health Commission.乐城国际特许药品进口政策；临床使用由省卫生健康委员会监管。
Cost费用说明
Uwell Cloud does not publish a figure for medical treatment. The hospital quotes the clinical cost after pre-screening and bills you directly — Uwell Cloud never collects medical fees. Uwell Cloud's own coordination fee is published in full on the service-packages page.优健云不公布医疗费用金额。临床费用由医院在预筛后报价并直接向患者结算，优健云不代收任何医疗费用。优健云自身的服务协调费已在服务套餐页完整公示。